HAMVX | VMVAX | HAMVX / VMVAX | |
Total Expense Ratio | 0.85 | 0.07 | 1,214% |
Annual Report Gross Expense Ratio | 0.90 | 0.07 | 1,286% |
Fund Existence | 23 years | 14 years | - |
Gain YTD | 0.544 | 0.658 | 83% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 50000 | 3000 | 1,667% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 346M | 29.9B | 1% |
Annual Yield % from dividends | 1.32 | 2.31 | 57% |
Returns for 1 year | 2.88 | 7.71 | 37% |
Returns for 3 years | 15.83 | 25.17 | 63% |
Returns for 5 years | 69.66 | 70.39 | 99% |
Returns for 10 years | 30.73 | 81.01 | 38% |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
JIVAX | 30.36 | N/A | N/A |
JPMorgan U.S. Applied Data Sci Val A | |||
EMWLX | 17.83 | N/A | N/A |
Lord Abbett Emerging Markets Equity R6 | |||
AMIGX | 81.68 | N/A | N/A |
Amana Growth Institutional | |||
AIOCX | 9.47 | N/A | N/A |
American Century International Opps C | |||
VAGVX | 28.06 | N/A | N/A |
Vanguard Advice Select Global Value Adml |